Christiane Auray-Blais, LLM, PhD, is the director of the Quebec Provincial Mass Urinary Screening Program for hereditary metabolic disorders. She obtained a PhD in radiobiology from the Université de Sherbrooke and postdoctoral studies from Duke University Medical Center, North Carolina. She has a master’s degree in health law from the Université de Sherbrooke. She is the author of 178 publications, abstracts and articles. She is an assistant professor in the Department of Pediatrics and the scientific director for the Waters-CHUS Expertise Centre in Clinical Mass Spectrometry. She is the principal investigator and/or co-investigator in numerous research grants for lysosomal storage disorders (Fabry disease and mucopolysaccharidoses), biomarker discovery and method validation using mass spectrometry. Her laboratory is also focused on biomarker discovery for prematurity in newborns and gestational diabetes. She is a co-investigator for a project on gene therapy and Fabry disease. She has received awards for her expertise in screening newborns in Quebec.
Associated Grants
-
Alpha-Galactosidase A and Glycosphingolipid Metabolites as Putative Biomarkers for Parkinson’s Disease
2013